Divisions of Cardiovascular Surgery and Cardiovascular Diseases, Mayo Clinic, Rochester, MN 55905, USA.
J Thorac Cardiovasc Surg. 2012 Feb;143(2):303-9. doi: 10.1016/j.jtcvs.2011.10.059. Epub 2011 Dec 10.
Many patients with symptomatic hypertrophic cardiomyopathy have minimal left ventricular outflow tract gradients, and there is uncertainty whether their limitation is due to diastolic dysfunction or labile outflow tract obstruction. The purpose of this study was to characterize the clinical presentation and outcome of septal myectomy in patients with hypertrophic cardiomyopathy and latent obstruction.
Among 749 patients who underwent septal myectomy, 249 had latent obstruction with minimal (0-30 mm Hg) resting gradients preoperatively. All were symptomatic and had more severe left ventricular outflow tract obstruction provoked by Valsalva maneuver or amyl nitrite inhalation during Doppler echocardiography or by stimulation with isoproterenol during catheterization. Clinical characteristics, survival, and functional outcome of these patients were compared with those of 500 patients with more severe resting left ventricular outflow tract obstruction who underwent myectomy during the same period.
Compared with those with severe obstruction, more patients with latent obstruction were male (63% vs 52%, P < .003), but ages were similar (53 ± 14 years vs 52 ± 15 years). Preoperative symptoms and functional limitation were similar in the 2 groups with 86% and 85%, respectively, having New York Heart Association class III or IV disability. Among patients with latent obstruction, mixed venous oxygen saturation was 61.6% ± 19.0% of predicted compared with 56.8% ± 17.3% for those with severe resting obstruction (P < .008). Septal thickness was less in patients with latent obstruction (20 ± 9 mm vs 22 ± 15 mm, P < .001). Early mortality was 1% in each group, and survival at 5 and 10 years was 93% and 87%, respectively, for patients with latent obstruction compared with 93% and 74%, respectively, for patients with severe resting obstruction preoperatively (P = .34). Self-reported late functional status was similar; 3 to 5 years postoperatively, 81% of patients with latent obstruction preoperatively were in New York Heart Association class I or II compared with 77% of patients with severe resting obstruction.
Patients with obstructive hypertrophic cardiomyopathy who have low resting gradients and latent obstruction may have limiting symptoms comparable to those of patients with more severe resting gradients. Septal myectomy should be offered to these patients because survival and symptom relief are excellent, suggesting that dynamic obstruction is the major hemodynamic problem rather than diastolic dysfunction.
许多有症状的肥厚型心肌病患者的左心室流出道梯度很小,其限制是否由于舒张功能障碍或流出道梗阻不稳定引起尚不确定。本研究的目的是描述肥厚型心肌病和隐匿性梗阻患者行室间隔心肌切除术的临床表现和结局。
在 749 例行室间隔心肌切除术的患者中,249 例术前存在最小(0-30mmHg)静息梯度的隐匿性梗阻。所有患者均有症状,在多普勒超声心动图行瓦尔萨尔瓦动作或亚硝酸异戊酯吸入或在导管插入术时用异丙肾上腺素刺激时,左心室流出道梗阻更为严重。比较这些患者与同期行心肌切除术的 500 例静息左心室流出道梗阻较重患者的临床特征、生存和功能结局。
与梗阻较重的患者相比,更多的隐匿性梗阻患者为男性(63% vs 52%,P<.003),但年龄相似(53±14 岁 vs 52±15 岁)。两组患者术前症状和功能受限均相似,分别有 86%和 85%的患者为纽约心脏协会(NYHA)心功能Ⅲ或Ⅳ级。在隐匿性梗阻患者中,混合静脉血氧饱和度为预计值的 61.6%±19.0%,而静息梗阻较重的患者为 56.8%±17.3%(P<.008)。隐匿性梗阻患者的室间隔厚度较小(20±9mm vs 22±15mm,P<.001)。两组早期死亡率均为 1%,隐匿性梗阻患者的 5 年和 10 年生存率分别为 93%和 87%,而术前静息梗阻较重的患者分别为 93%和 74%(P=.34)。术后 3-5 年,术前为隐匿性梗阻的患者中,81%报告 NYHA 心功能Ⅰ或Ⅱ级,而静息梗阻较重的患者为 77%(P=.34)。
静息梯度低且存在隐匿性梗阻的梗阻性肥厚型心肌病患者可能有与静息梯度较重患者相当的限制症状。应向这些患者提供室间隔心肌切除术,因为生存和症状缓解均良好,提示动态梗阻是主要的血流动力学问题,而不是舒张功能障碍。